Last Price | 0.28 | Max Price | 0.45 |
Min Price | 0.15 | 1 Year return | -75.00 |
Sector | Health Care | Subsector | Pharmaceuticals |
Contact info:Country: France
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 7 | 615,670 | 0.00 % |
2020 | 13 | 638,104 | 0.00 % |
2021 | 7 | 727,997 | 0.00 % |
2022 | 3 | 787,317 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
Nicox's core business is the pharmaceutical sector. The global pharmaceutical companies gained over the past 10 years on average 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.
Nicox didn't pay out any dividends (in the past 5 years).
Last year the balance sheet of the French company was worth 163,35 million euros. The total debt was around 62,02 million euros. This is 37,97 percent of the total balance sheet.
At the end of 2015 the French company had around 22,36 million stocks listed.
All the annual reports of Nicox are available here. More information about Nicox can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
10
|
0
|
2
|
4
|
7
|
13
|
Costs |
38
|
19
|
6
|
22
|
26
|
31
|
Profit |
-28
|
-19
|
-4
|
-18
|
-19
|
-18
|
Margin of profit |
-280.52
|
-95200.00
|
-156.71
|
-456.33
|
-275.80
|
-140.20
|
ROI |
-27.57
|
-18.21
|
-2.86
|
-16.18
|
-17.31
|
-17.95
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
101
|
105
|
127
|
114
|
109
|
101
|
Debt |
62
|
44
|
24
|
25
|
34
|
41
|
Total assets |
163
|
149
|
151
|
139
|
143
|
142
|
Solvency |
62.03
|
70.29
|
84.06
|
82.00
|
76.54
|
70.88
|
Cash |
30
|
29
|
41
|
22
|
28
|
47
|
Cashflow |
-22
|
-26
|
-12
|
-19
|
-16
|
-5
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-0.36
|
-0.58
|
-0.52
|
-0.77
|
-0.48
|
-0.13
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
9.12
|
8.53
|
10.14
|
5.01
|
4.36
|
Eps |
-0.80
|
-0.12
|
-0.62
|
-0.62
|
-0.54
|
Price/earnings-ratio |
-11.40
|
-71.08
|
-16.35
|
-8.08
|
-0.52
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
4.18
|
4.31
|
3.82
|
3.29
|
2.73
|
Market to book |
0.46
|
0.51
|
0.38
|
0.66
|
9.76
|
Cashflow per stock |
-1.03
|
-0.42
|
-0.64
|
-0.48
|
-0.15
|
Stocks |
25
|
29
|
30
|
33
|
37
|
Market Cap |
228.04
|
250.77
|
301.35
|
166.49
|
10.33
|
Date
|
Price
|
---|---|
17 Dec 2024
|
0.28
|
10 Dec 2024
|
0.28
|
06 Dec 2024
|
0.27
|
03 Dec 2024
|
0.21
|
29 Nov 2024
|
0.21
|
27 Nov 2024
|
0.22
|
13 Nov 2024
|
0.24
|
08 Nov 2024
|
0.25
|
05 Nov 2024
|
0.25
|
31 Oct 2024
|
0.26
|
29 Oct 2024
|
0.26
|
23 Oct 2024
|
0.26
|
19 Oct 2024
|
0.27
|
16 Oct 2024
|
0.27
|
14 Oct 2024
|
0.28
|
05 Oct 2024
|
0.27
|
02 Oct 2024
|
0.30
|
27 Sep 2024
|
0.27
|
20 Sep 2024
|
0.23
|
17 Sep 2024
|
0.15
|
13 Sep 2024
|
0.16
|
28 Aug 2024
|
0.18
|
26 Aug 2024
|
0.18
|
23 Aug 2024
|
0.18
|
11 Aug 2024
|
0.17
|
07 Aug 2024
|
0.17
|
05 Aug 2024
|
0.17
|
01 Aug 2024
|
0.18
|
30 Jul 2024
|
0.18
|
26 Jul 2024
|
0.17
|